ANAPLASTIC LYMPHOMA KINASE

Clinical trials for ANAPLASTIC LYMPHOMA KINASE explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC LYMPHOMA KINASE trials appear

Sign up with your email to follow new studies for ANAPLASTIC LYMPHOMA KINASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Doctors track lung cancer Drug's Real-World performance

Disease control Recruiting now

This study is monitoring the safety and effectiveness of the lung cancer drug brigatinib in real-world medical settings in South Korea. It will follow about 257 adults with ALK-positive advanced lung cancer who are starting brigatinib treatment for the first time. The main goal i…

Matched conditions: ANAPLASTIC LYMPHOMA KINASE

Sponsor: Takeda • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

ANAPLASTIC LYMPHOMA KINASE

Get alerted when new ANAPLASTIC LYMPHOMA KINASE trials appear

Doctors track lung cancer Drug's Real-World performance